Form 4: Arteris VP Sells Shares for Tax, 10b5-1 Plan

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold a total of 7,627 shares of common stock in early October 2025, primarily to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Summary

• Paul L. Alpern, the Vice President and General Counsel of Arteris, Inc. (AIP), reported sales of the company's common stock.
• On October 2, 2025, Alpern sold a total of 2,877 shares (691, 1,008, and 1,178 shares) at a price of $10.9208 per share. These sales were conducted to satisfy tax liabilities arising from the release of restricted stock units.
• On October 3, 2025, an additional 4,750 shares were sold at a weighted average price of $11.082 per share. Individual transaction prices for these shares ranged from $10.81 to $11.30.
• The sale on October 3, 2025, was executed pursuant to a Rule 10b5-1 trading plan, which Alpern adopted on June 5, 2025.
• Following these transactions, Alpern's direct beneficial ownership of Arteris, Inc. common stock decreased to 65,960 shares.

Sentiment

Score: 5

Explanation: The filing reports routine insider stock sales, some for tax obligations and others under a pre-arranged trading plan, which are common and do not inherently indicate a positive or negative outlook for the company's performance.

Negatives

• The sale of 7,627 shares by a key executive, even for pre-planned reasons, reduces their direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: May observe a slight reduction in a key executive's direct ownership, though the reasons (tax, 10b5-1 plan) are generally considered routine and not indicative of a negative outlook.

Key Dates

Recommendation

The Form 4 details routine insider stock sales by a VP, primarily for tax obligations and under a pre-arranged 10b5-1 plan. These transactions are common and do not provide new fundamental information about the company's performance or future prospects that would warrant a change in investment recommendation based solely on this filing.

Keywords

Arteris, AIP, Paul Alpern, Form 4, insider trading, stock sale, 10b5-1 plan, restricted stock units, tax liability